Here are six points:
1. China has experienced an increase in spinal fusion surgeries due to better reimbursements and more patients opting for minimally invasive surgery.
2. An aging population and increasing incomes are driving more people with back issues to undergo spinal fusion surgery.
3. New technologies, such as improved implant materials, encourage more people to seek spinal fusion surgery.
4. The Chinese government and economic growth have facilitated spinal treatment for patients in rural areas by opening doors for better access to healthcare.
5. The market faces some obstacles in high surgery costs and alternative options, such as Intradiscal Electrothermal Annuloplasty.
6. Trauson, DePuy Synthes, Biomet, Medtronic, NuVasive, Stryker, Zimmer, Orthofix International, B. Braun Aesculap and Weigao Orthopaedic Device lead the market.
More articles on devices:
HSS conducts studies on a new modular partial wrist replacement: 5 takeaways
Wire stimulator technology provides chronic pain relief for San Antonio patients: 4 key points
Nextremity Solutions acquires Del Palma Orthopedics’ foot fusion technology: 4 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
